ӰԺ

Point of care, point of impact: 
Accelerating equitable access to care to improve First Nations’ health outcomes across Australia
Immediate, reliable test results are transforming treatment decisions for Indigenous communities.

Click to watch the 7-minute video about how the award-winning QAAMS program has improved chronic disease management for the Australian Indigenous population by bringing health services closer to the patient.

Diabetes has emerged as one of the most pressing global health challenges of our time, affecting over 589 million adults worldwide—a number projected to soar to 853 million by 2050, according to the International Diabetes Federation (IDF)1.

Among the most impacted populations are Aboriginal and Torres Strait Islander peoples in Australia, where diabetes prevalence has surged by nearly 40% in the past decade, now affecting 15.5% of adults—and as high as 21.7% in remote communities. Alarmingly, youth-onset type 2 diabetes is rising rapidly, with some of the highest rates globally found in Central and Northern Australia. 2,3

These figures underscore the urgent need for culturally tailored prevention, early diagnosis, and care strategies to address the widening health gap and improve outcomes for Indigenous Australians.2,3



QAAMS logo flinders  image

Established in 1999 with a small pilot of 48 health services, the QAAMS (Quality Assurance for Aboriginal and Torres Strait Islander Medical Services) Program provides a culturally appropriate and clinically effective diabetes diagnosis and management service for First Nations people. The Program is funded by the Commonwealth Government Department of Health.

The centerpiece of the QAAMS Program is the use of on-site POC pathology testing (POCT) to assist diabetes diagnosis and management.

•    A point-of-care (POC) HbA1c test can diagnose diabetes by measuring average blood sugar levels over the past 90 days. Unlike traditional lab tests, POC HbA1c testing provides immediate results, allowing for faster diagnosis and the opportunity to alter treatment options.  

•    Urine albumin:creatinine ratio (ACR) is a urine test that identifies early signs of renal disease4,5 the main complication of diabetes.

QAAMS map
The evolution of QAAMS coverage around the country, reaching over 240 sites in 2024.

According to Professor Mark Shephard, Founding Director and the Inaugural QAAMS Program Manager, QAAMS has had a fascinating evolution, hitting the 100-site mark in 2008 and reaching 200 sites by 2015. When the program celebrated its 25th anniversary in 2024, it had reached the 240-site milestone.

The indigenous population has a high risk of diabetes and early renal disease. With 80% of the testing sites in rural and remote locations, it is often difficult for patients to schedule follow-up visits. They really appreciate the convenience and accessibility of point-of-care testing because they can get their results right away and work with their doctor to manage their condition.

In addition, having Aboriginal health professionals positioned as the principal point-of-care operators has been essential as they are able to build trusted relationships with their patients. The embedding of cultural governance into the program via the First Nations Leadership Forum helped lead to QAAMS overall success.

The QAAMS POC testing program delivers impactful results that have set the benchmark in POC testing in Australia. The program has received national and international recognition for its success in navigating the cultural complexities of indigenous healthcare.6,7Siemens Healthineers is proud to have been a trusted partner of the QAAMS program throughout its journey.


Measuring HbA1c for diabetes management

Hemoglobin (Hb) is a protein found inside red blood cells that carries oxygen from the lungs to the rest of the body and carries carbon dioxide from all organs to the lungs. Glucose in the blood can bond with hemoglobin to form glycated hemoglobin, or HbA1c. If there is excess glucose in the blood, the level of HbA1c will be higher than normal. 

By measuring HbA1c, doctors can gauge your average blood sugar levels from the last 2-3 months and thereby provide a more tailored treatment plan. HbA1c measurement can also show whether treatment plans and lifestyle choices have been effective.8

The ADA recommends a glycemic target of <7% HbA1c for non-pregnant adults.



Illustration of 2 red blood cells. One represents low HbA1c and has a few blue circles representing glycated hemoglobin. The other shows high HbA1c with more blue circles on the red blood cell.

High HbA1c levels are characterized by higher amounts of glycated hemoglobin in red blood cells.


HbA1c is usually measured either as a percent (%) of the total hemoglobin level or in mmol/mol.8

1.
2.
3.
4.
5.
6.
7.
8.